SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-11-044757
Filing Date
2011-08-09
Accepted
2011-08-09 10:56:45
Documents
11
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 v229838_10q.htm 10-Q 615751
2 v229838_ex31-1.htm EX-31.1 10189
3 v229838_ex31-2.htm EX-31.2 10298
4 v229838_ex32-1.htm EX-32.1 6153
5 v229838_ex32-2.htm EX-32.2 6460
  Complete submission text file 0001144204-11-044757.txt   1812505

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE rprx-20110630.xml EX-101.INS 112268
7 XBRL SCHEMA FILE rprx-20110630.xsd EX-101.SCH 12733
8 XBRL CALCULATION FILE rprx-20110630_cal.xml EX-101.CAL 37333
9 XBRL DEFINITION FILE rprx-20110630_def.xml EX-101.DEF 86815
10 XBRL LABEL FILE rprx-20110630_lab.xml EX-101.LAB 96761
11 XBRL PRESENTATION FILE rprx-20110630_pre.xml EX-101.PRE 94207
Mailing Address 2408 TIMBERLOCH PLACE B-7 THE WOODLANDS TX 77380
Business Address 2408 TIMBERLOCH PL SUITE B-7 WOODLANDS TX 77380 2817193400
REPROS THERAPEUTICS INC. (Filer) CIK: 0000897075 (see all company filings)

IRS No.: 760233274 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15281 | Film No.: 111019376
SIC: 2836 Biological Products, (No Diagnostic Substances)